Secondhand Smoke Reduces Chemotherapy Effectiveness in Head and Neck Cancer Patient

A groundbreaking study by researchers at the University of Oklahoma Health Sciences has revealed that exposure to secondhand smoke during chemotherapy can significantly reduce treatment effectiveness for head and neck cancer patients.

The study, led by Dr. Lurdes Queimado and published in the International Journal of Molecular Sciences, found that twice as much chemotherapy was needed to kill cancer cells exposed to secondhand smoke compared to unexposed cells. Furthermore, the cancer cells that survived treatment were more likely to replicate indefinitely.

Queimado's team discovered that secondhand smoke alters the expression of proteins involved in drug resistance, limiting chemotherapy's ability to enter and kill cancer cells. This study highlights the importance of avoiding secondhand smoke exposure during cancer treatment, even for non-smokers.

The findings have major implications for cancer patients and their physicians, emphasizing the need for comprehensive smoking cessation plans that include family members to improve treatment outcomes.

Read more-